Analisis Time Series dan Cross Section Perbandingan Kinerja Keuangan Studi Kasus Pada PT Adaro Energy, PT Indika Energy, dan PT Harum Energy Tahun 2019 - 2021
Trending: Jurnal Manajemen dan Ekonomi · 2022
DOI: 10.30640/trending.v1i1.472 ↗Kurz gefasst
Fachartikel in der Zeitschrift Trending: Jurnal Manajemen dan Ekonomi, 2022. Verfasst von Fahrizal Akhmad Zein und 2 weiteren Autor:innen.
Abstract (Originalsprache)
This study aims to analyze the time series and cross section of financial performance comparisons that occurred at PT Adaro Energy, PT Indika Energy, and PT Harum Energy in 2019-2021. The research method used is descriptive qualitative by taking data sources obtained from the corporate websites of PT Adaro Energy Tbk, PT Harum Energy, PT Indika Energy Tbk and the website idx.com. The results found that PT HRUM is a company with the best prospects seen from various comparisons. While PT INDY is considered to have the best management control compared to the other two companies. PT ADRO has no problems that need to be underlined, they just need to improve a little.
Zitieren
APA
Zein, F. A., Setiawan, F. D., & Ardiansyah, R. (2022). Analisis Time Series dan Cross Section Perbandingan Kinerja Keuangan Studi Kasus Pada PT Adaro Energy, PT Indika Energy, dan PT Harum Energy Tahun 2019 - 2021. Trending: Jurnal Manajemen dan Ekonomi. https://doi.org/10.30640/trending.v1i1.472
Vancouver
Zein FA, Setiawan FD, Ardiansyah R. Analisis Time Series dan Cross Section Perbandingan Kinerja Keuangan Studi Kasus Pada PT Adaro Energy, PT Indika Energy, dan PT Harum Energy Tahun 2019 - 2021. Trending: Jurnal Manajemen dan Ekonomi. 2022. doi:10.30640/trending.v1i1.472
BibTeX
@article{Zein2022,
author = {Zein, Fahrizal Akhmad and Setiawan, Farrel Daffa and Ardiansyah, Rendy},
title = {Analisis Time Series dan Cross Section Perbandingan Kinerja Keuangan Studi Kasus Pada PT Adaro Energy, PT Indika Energy, dan PT Harum Energy Tahun 2019 - 2021},
journal = {Trending: Jurnal Manajemen dan Ekonomi},
year = {2022},
doi = {10.30640/trending.v1i1.472}
}
EUVIMED